Visual systemizing preference in children with autism: A randomized controlled trial of intranasal oxytocin

被引:11
|
作者
Strathearn, Lane [1 ,2 ,3 ]
Kim, Sohye [2 ,3 ]
Bastian, D. Anthony [2 ,4 ]
Jung, Jennifer [2 ]
Iyengar, Udita [2 ,5 ]
Martinez, Sheila [2 ]
Goin-Kochel, Robin P. [2 ,3 ]
Fonagy, Peter [2 ,5 ]
机构
[1] Univ Iowa, Iowa City, IA 52246 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Houston, TX 77030 USA
[4] Texas Tech Paul L Foster Sch Med, El Paso, TX USA
[5] UCL, London, England
关键词
HIGH-FUNCTIONING AUTISM; SOCIAL MOTIVATION; ASPERGER-SYNDROME; ADULTS; QUOTIENT; BRAIN; NEUROSCIENCE; BEHAVIORS; DISORDER; EMOTION;
D O I
10.1017/S0954579417001018
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Several studies have suggested that the neuropeptide oxytocin may enhance aspects of social communication in autism. Little is known, however, about its effects on nonsocial manifestations, such as restricted interests and repetitive behaviors. In the empathizing-systemizing theory of autism, social deficits are described along the continuum of empathizing ability, whereas nonsocial aspects are characterized in terms of an increased preference for patterned or rule-based systems, called systemizing. We therefore developed an automated eye-tracking task to test whether children and adolescents with autism spectrum disorder (ASD) compared to matched controls display a visual preference for more highly organized and structured (systemized) real-life images. Then, as part of a randomized, double-blind, placebo-controlled crossover study, we examined the effect of intranasal oxytocin on systemizing preferences in 16 male children with ASD, compared with 16 matched controls. Participants viewed 14 slides, each containing four related pictures (e.g., of people, animals, scenes, or objects) that differed primarily on the degree of systemizing. Visual systemizing preference was defined in terms of the fixation time and count for each image. Unlike control subjects who showed no gaze preference, individuals with ASD preferred to fixate on more highly systemized pictures. Intranasal oxytocin eliminated this preference in ASD participants, who now showed a similar response to control subjects on placebo. In contrast, control participants increased their visual preference for more systemized images after receiving oxytocin versus placebo. These results suggest that, in addition to its effects on social communication, oxytocin may play a role in some of the nonsocial manifestations of autism.
引用
收藏
页码:511 / 521
页数:11
相关论文
共 50 条
  • [1] Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial
    Anagnostou, Evdokia
    Soorya, Latha
    Chaplin, William
    Bartz, Jennifer
    Halpern, Danielle
    Wasserman, Stacey
    Wang, A. Ting
    Pepa, Lauren
    Tanel, Nadia
    Kushki, Azadeh
    Hollander, Eric
    [J]. MOLECULAR AUTISM, 2012, 3
  • [2] Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial
    Evdokia Anagnostou
    Latha Soorya
    William Chaplin
    Jennifer Bartz
    Danielle Halpern
    Stacey Wasserman
    A Ting Wang
    Lauren Pepa
    Nadia Tanel
    Azadeh Kushki
    Eric Hollander
    [J]. Molecular Autism, 3
  • [3] Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
    Daniels, Nicky
    Moerkerke, Matthijs
    Steyaert, Jean
    Bamps, Annelies
    Debbaut, Edward
    Prinsen, Jellina
    Tang, Tiffany
    Van der Donck, Stephanie
    Boets, Bart
    Alaerts, Kaat
    [J]. MOLECULAR AUTISM, 2023, 14 (01)
  • [4] Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
    Nicky Daniels
    Matthijs Moerkerke
    Jean Steyaert
    Annelies Bamps
    Edward Debbaut
    Jellina Prinsen
    Tiffany Tang
    Stephanie Van der Donck
    Bart Boets
    Kaat Alaerts
    [J]. Molecular Autism, 14
  • [5] Use of Intranasal Oxytocin to Treat Adult Autism Spectrum Disorder: A Randomized Double Blind Controlled Trial
    Niri, S. Faraji
    Alaghband-rad, J.
    Motamed, M.
    Hojjati, S. A.
    Alipour, S. Seyed
    Mohebbi, N.
    [J]. EUROPEAN PSYCHIATRY, 2024, 67 : S48 - S49
  • [6] RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION OF INTRANASAL OXYTOCIN FOR AUTISM SPECTRUM DISORDER
    Spanos, Marina
    Bethea, Terrence
    Alderman, Cheryl
    Johnson, Jacqueline
    Chandrasekhar, Tara
    Sikich, Linmarie
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S162 - S162
  • [7] INTRANASAL OXYTOCIN FOR AUTISM SPECTRUM DISORDER: ASSESSING LONG-TERM SAFETY AND EFFICACY IN A RANDOMIZED CONTROLLED TRIAL
    Chang, Christel L.
    Koh, John M. Y.
    Wong, C. M.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S287 - S287
  • [8] The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial
    Guastella, Adam J.
    Gray, Kylie M.
    Rinehart, Nicole J.
    Alvares, Gail A.
    Tonge, Bruce J.
    Hickie, Ian B.
    Keating, Caroline M.
    Cacciotti-Saija, Cristina
    Einfeld, Stewart L.
    [J]. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2015, 56 (04) : 444 - 452
  • [9] A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
    J. Fastman
    J. Foss-Feig
    Y. Frank
    D. Halpern
    H. Harony-Nicolas
    C. Layton
    S. Sandin
    P. Siper
    L. Tang
    P. Trelles
    J. Zweifach
    J. D. Buxbaum
    A. Kolevzon
    [J]. Molecular Autism, 12
  • [10] A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
    Fastman, J.
    Foss-Feig, J.
    Frank, Y.
    Halpern, D.
    Harony-Nicolas, H.
    Layton, C.
    Sandin, S.
    Siper, P.
    Tang, L.
    Trelles, P.
    Zweifach, J.
    Buxbaum, J. D.
    Kolevzon, A.
    [J]. MOLECULAR AUTISM, 2021, 12 (01)